Clinical Trials Logo
  1. Home
  2. Osteoarthritis
  3. NCT04839315
  4. Details
NCT04839315 Clinical Trial

COVID-19 Vaccination in Rheumatic Disease Patients

Osteoarthritis Clinical Trial

Official title:
Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT04839315
Other study ID # 21-000501
Secondary ID
Status Terminated
Phase Early Phase 1
First received
Last updated
Start date February 15, 2021
Est. completion date February 9, 2022

Study information
Verified date May 2022
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The research is being done to study the immune responses to COVID-19 vaccination in patients with rheumatic diseases.

Description:

Because patients treated with immunosuppressive agents have been excluded from initial clinical trials, and most patients with rheumatic diseases are taking immunosuppressants, the immune responses towards the mRNA COVID19 vaccines in these patients remains unknown. The goal is to study the immune response to COVID-19 vaccination in patients with rheumatic diseases. Blood samples collected before and longitudinally after mRNA-based COVID-19 vaccination (i.e., Pfizer and Moderna vaccines) will enable detailed immunological investigation of the interaction between COVID-19 vaccination and rheumatic diseases. These efforts will provide novel insights into the COVID-19 vaccine response in patients with rheumatic diseases, and eventually would inform clinical management to improve patient care.

Recruitment information / eligibility
Status Terminated
Enrollment 58
Est. completion date February 9, 2022
Est. primary completion date February 9, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Rheumatologist confirmed diagnosis of one of the following diagnoses: - Systemic lupus erythematosus; - Sjogren syndrome; - Inflammatory myositis; - Psoriatic arthritis; - Osteoarthritis; - Gout; - Ankylosing spondylitis; - IBD-related arthritis. Exclusion Criteria: - Active infection or untreated malignancy (other than skin cancer) at enrollment. - Pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Biological:
• mRNA COVD19 vaccine
Subjects will receive two doses of mRNA based COVID19 vaccines.

Locations
Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Humoral responses towards mRNA COVID-19 vaccines We aim to examine SARS-Cov2 specific antibody, and autoantibody generation 2 weeks to 6 months after second dose of vaccine
Secondary Cellular immune responses towards mRNA COVID-19 vaccines measurement of immune cell distributions, type I interferon activity, and SARS-Cov2 specific T cell responses 2 weeks to 6 months after second dose of vaccine
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A

External Links